TickerFactsScreenerDevelopers

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Net Income

Annual figures by fiscal year, from SEC filings.

2003: -$95.2K2004: -$751.3K2005: -$6.73M2006: -$19.96M2007: -$30.71M2008: -$27.24M2009: -$19.31M2010: -$6.96M2011: -$3.49M2012: -$22.11M2013: -$31.70M2014: -$58.73M2015: -$91.94M2016: -$81.72M2017: -$34.38M2018: -$54.45M2019: $67.97M2020: -$84.55M2021: -$140.85M2022: -$176.49M2023: -$209.28M2024: -$609.69M2025: $30.11M$30.11M
2003Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$30.11M+104.9%
2024-$609.69M-191.3%
2023-$209.28M-18.6%
2022-$176.49M-25.3%
2021-$140.85M-66.6%
2020-$84.55M-224.4%
2019$67.97M+224.8%
2018-$54.45M-58.4%
2017-$34.38M+57.9%
2016-$81.72M+11.1%
2015-$91.94M-56.6%
2014-$58.73M-85.2%
2013-$31.70M-43.4%
2012-$22.11M-533.1%
2011-$3.49M+49.8%
2010-$6.96M+64.0%
2009-$19.31M+29.1%
2008-$27.24M+11.3%
2007-$30.71M-53.9%
2006-$19.96M-196.5%
2005-$6.73M-796.3%
2004-$751.3K-688.8%
2003-$95.2K—